Back to Top Skip to main content Skip to sub-navigation

Military Health System participating in COVID-19 vaccine trial

Woman measuring out a vaccine into a needle Five military medical treatment facilities are participating in a Phase 3 clinical trial testing a COVID-19 vaccine in development with AstraZeneca. (Photo by Air Force Staff Sgt. Joshua Garcia.)

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Vaccine Trials

Five military medical treatment facilities in the National Capital Region, Texas, and California are participating in a phase 3 clinical trial testing the AstraZeneca COVID-19 vaccine in development under Operation Warp Speed.  The DoD sites are actively enrolling study participants, with a goal to recruit up to 1,000 volunteers in each of the three market areas towards the total AstraZeneca clinical trial enrollment of 30,000 people.

Operation Warp Speed, a multiagency U.S. Government effort led by the Department of Health and Human Services and the Department of Defense, is working with the private sector with the aims to deliver safe and effective COVID-19 vaccine doses to the American public beginning January 2021.

OWS is funding clinical trials evaluating several vaccine candidates which were selected based on promising data on safety, immune response, and protection in animal studies and safety and immune response data in early-stage trials in humans. Each of the trials is designed to collect data on how well a vaccine candidate protects against COVID-19 and on the safety of the vaccine candidate in a larger population, including people most at risk.  

“The Department of Defense continues to play a key role in the development of a potential COVID-19 vaccine,” said Thomas McCaffery, assistant secretary of Defense for Health Affairs. “Now that vaccines have passed the first phases of testing for safety, dosing, and response, we have moved into the next phase where volunteers are needed to join large clinical studies. We are excited to have several sites supporting these next steps in the vaccine development process.”

Large phase 3 clinical trials are a necessary part of the rigorous scientific process to test the efficacy and safety of a vaccine in a real-world setting with a large population sample, said Air Force Col (Dr.) Jessica Cowden, chief medical officer of the DoD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnology Vaccine Acceleration Project.

“Phase 3 studies are designed to evaluate if the vaccine can prevent disease in the populations of people that the vaccine is being developed to protect,” said Cowden. “Phase 3 studies are large and usually involve some people who are at risk for infection and disease.”

The National Institute of Allergy and Infectious Diseases at the National Institutes of Health established a network of infectious disease experts and research partners, termed the Coronavirus Prevention Network, or CoVPN, to rapidly and thoroughly evaluate U.S. government-sponsored COVID-19 vaccines. The CoVPN website (https://www.coronaviruspreventionnetwork.org/) provides general information about products being developed to prevent COVID-19 and about clinical trials.

According to the CoVPN, interested volunteers must be adults aged 18 and older to be screened for these initial trials. The CoVPN recognizes the importance of including volunteers who are more likely to get COVID-19, such as those over the age of 65 or with underlying medical conditions; as well as people who work in an essential job, live in a densely populated area, or represent a racial and ethnic group greatly impacted by the epidemic.

Representation by such groups matters in Phase 3 trials because vaccines need to be tested in populations who are at most risk of being exposed to the disease and getting sick in the real world, explained Cowden. “At-risk populations shouldn’t bear a disproportionate burden of research, but they need to be represented,” she said

The selected DoD sites are currently enrolling volunteers for the AstraZeneca clinical trial, according to Cowden. The trial is a randomized control, double-blind study, meaning volunteers will either receive the study vaccine or saline. “The study team and the participant will be blinded so that they won’t know which the participant received until the end of the study,” Cowden said. AstraZeneca’s vaccine candidate is in late-stage clinical trials ongoing in the U.K., Brazil and South Africa.

“Participating in a vaccine clinical trial is voluntary but is also critically vital to ensure that the overall effort is ultimately successful,” said Dr. Sean Biggerstaff, acting deputy director, DHA Research and Development Directorate. “Volunteers should also know safety remains an overriding priority for anyone participating in clinical trials.”

Military health beneficiaries who wish to volunteer for the AstraZeneca COVID-19 vaccine at a nearby military medical treatment facility (or at a civilian site close to home) can contact the local study team directly to request more information or can register on the CoVPN website and consent to be contacted by a research team. If registering on the CoVPN site, interested volunteers should enter the appropriate code in parenthesis from the list below, or enter their ZIP code to join the registry. Site contact information is included here:

At this point, the DoD is only participating in the AstraZeneca study. Additional DoD sites are being prepared for participation in other clinical trials of vaccines and monoclonal antibodies to prevent COVID-19, said Cowden.

“Having a safe and effective COVID-19 vaccine is what we need to protect people and get life back to normal, but in order to get to that point, we have to do these clinical trials,” explained Cowden. “These big Phase 3 clinical trials with a lot of people participating are critical so we can get the information we need to determine if a vaccine candidate is safe and can prevent COVID-19.”

You also may be interested in...

Printable VAX Fact How Many Doses of the Vaccine Will I Get?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Printable VAX Fact How Much will the COVID-19 Vaccine Cost?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Printable VAX Fact Do I Have to Get the COVID-19 Vaccine?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Printable VAX Fact Will TRICARE Cover the COVID Vaccine?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Printable VAX Fact Getting COVID and Flu Vaccine at Once

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Printable VAX Fact Where can I get the COVID-19 Vaccine?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

COVID-19 vaccinations reaching smaller clinics, facilities

Article
2/10/2021
Military healthcare worker holding a vaccine needle

The pace of vaccinations should accelerate as the FDA approves newer vaccines for use.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

MHS Minute: A Path Forward in 2021

Video
2/10/2021
DHA Seal

Want to know more about what MHS organizations and partners did in 2020? For a full look at the MHS Minute series, click here: https://shorturl.at/eDL14

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

DOD Announces Use of Masks, Other Public Health Measures

Article
2/9/2021
Woman wearing a mask

Department of Defense updates the use of masks requirements to align to the most current CDC guidelines.

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit

COVID-19 vaccine rollout ongoing in U.S. Army Central footprint

Article
2/9/2021
Two healthcare workers, wearing masks, adding the COVID-19 vaccine to syringes

The COVID-19 vaccination program in the U.S. Army Central’s area of operations is underway.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Military, medical leaders discuss COVID-19 issues with Service Members

Article
2/8/2021
Mr. and Mrs. Milley, wearing masks, standing in front of various flags.

Fauci said it is impossible to get COVID-19 from the vaccine, and it will "absolutely not" enter into a person's DNA.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Weed ACH moves one step closer to phase 2 of COVID vaccine plan

Article
2/4/2021
Image of soldier getting a vaccine in her left arm

More and more individuals eligible under phase 1 continue to opt in to receive the COVID-19 vaccine, including those who previously had the disease.

Recommended Content:

COVID-19 Vaccine Efforts

DOD COVID-19 vaccine roll-out continues, eye on long-term readiness

Article
2/4/2021
Soldier getting a vaccine in his left arm

The impact of the COVID-19 vaccines on military readiness is unknown, but members are encouraged to get the shots as soon as they become available.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Blood donations remain vital for Service Member care

Article
2/3/2021
Man walking with assistance at a PT clinic

Putting a human face on the act of giving blood could help drive blood donations. And first-tme donors often become sustaining donors.

Recommended Content:

Heart Health Toolkit | Coronavirus | Convalescent Plasma Collection Program

Eliminating the pandemic - one shot at a time

Article
2/3/2021
Tom Danaher was one of approximately several hundred 75 years and older beneficiaries who were administered their initial dose of Moderna COVID-19 vaccine.

NHB / NMRTC Bremerton moves forward with the phased approach of the COVID-19 vaccines

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit
<< < ... 11 12 13 14 15  ... > >> 
Showing results 151 - 165 Page 11 of 36

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.